May 16, 2018

GlaxoSmithKline LLC v. Teva Pharmaceuticals USA, Inc.

View recent docket activity

Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.

Coverage

  1. February 11, 2022

    Sharply Split Full Fed. Circ. Won't Eye Skinny Label Ruling

    Six Federal Circuit judges on Friday said they won't disturb a panel's finding that generic-drug maker Teva induced doctors to infringe a GlaxoSmithKline patent with its "skinny-label" version of the drug Coreg, much to the frustration of three colleagues.

17 other articles on this case. View all »

Parties

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Direct access to case information and documents.
  • All significant new filings across U.S. federal district courts, updated hourly on business days.
  • Full-text searches on all patent complaints in federal courts.
  • No-fee downloads of the complaints and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

View the parties now

Already a subscriber? Click here to login